Loading organizations...
Key people at Lanting Capital.
Lanting Capital operates as a cross-border strategic consulting and investment firm, specializing in the healthcare sector, particularly pharmaceuticals. The firm provides advisory services and capital, leveraging deep industry knowledge to support companies within this complex market. Its approach integrates specialized life science expertise with financial strategies to foster development.
The firm was founded in 2017 by Ethan Wu and Yifei Wu. Their decision stemmed from recognizing unique opportunities within the healthcare and pharmaceutical industries. As seasoned pharmaceutical veterans and asset management experts, they combined skills to offer comprehensive support tailored to the sector's demands.
Lanting Capital serves businesses and innovators operating within the global healthcare and pharmaceutical landscapes. The firm's long-term vision centers on facilitating advancements and accelerating growth for enterprises shaping the future of medicine and patient care. It aims to be a critical partner in navigating the evolving dynamics of the life sciences market.
Key people at Lanting Capital.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 19, 2021 | Regor Therapeutics | $90.0M Series B | Lilly Asia Ventures | Loyal Valley Capital, TF Capital |